Trials in “True” Dyslipidemic Patients Are Urged to Reconsider Comprehensive Lipid Management as a Means to Reduce Residual Cardiovascular Risk
Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt.1436
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 29, 2019
Authors
Publisher
Wiley